Fundraising FoxAirsonett
Not stated on page, SE · 3 known investors
Find your way into Airsonett
Sign up to find every way you can get introduced to Airsonett
- Your email: who you already know at Airsonett, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Airsonett team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Airsonett develops Temperature Laminar Airflow (TLA) medical devices for non-pharmacologic treatment of allergic asthma and eczema. The company's flagship Air4 device is a CE-marked class I medical device and FDA-cleared class II device intended for home use to reduce allergens and airborne irritants in patients' breathing zones.
Investors · 3
Frequently asked questions
- What does Airsonett do?
- Airsonett develops Temperature Laminar Airflow (TLA) medical devices for non-pharmacologic treatment of allergic asthma and eczema. The company's flagship Air4 device is a CE-marked class I medical device and FDA-cleared class II device intended for home use to reduce allergens and airborne irritants in patients' breathing zones.
- Who are Airsonett's investors?
- Airsonett's investors include Industrifonden, SEB Venture Capital, FSG.
- Where is Airsonett headquartered?
- Airsonett is headquartered in Not stated on page, SE.